LM
Therapeutic Areas
Opko Biologis Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NGENLA (somatropin‑CTP) | Pediatric growth hormone deficiency | Approved |
| MOD‑4023 (hGH‑CTP) | Growth hormone deficiency | Phase 3 |
| Drug | Indication | Phase |
|---|---|---|
| NGENLA (somatropin‑CTP) | Pediatric growth hormone deficiency | Approved |
| MOD‑4023 (hGH‑CTP) | Growth hormone deficiency | Phase 3 |